Houlihan Lokey
Takashi Misato is a seasoned professional in the healthcare sector, currently serving as Managing Director and Head of Japanese Healthcare at Houlihan Lokey since February 2022. Prior to this role, Takashi was the President at GCA Healthcare and Head of Japanese Healthcare at GCA Group from April 2008 to February 2022, also holding the position of Executive Director. Takashi's experience includes a tenure as Senior Director and Venture Capitalist at Trans-Science, Inc. from October 2005 to December 2007, as well as serving as Senior Associate at PwC from January 2002 to September 2005. Earlier in the career trajectory, Takashi was a Consultant at Accenture from May 1999 to December 2001. Takashi holds a Master of Engineering and Bachelor of Engineering in Applied Chemistry from Waseda University, obtained in 1999 and 1997, respectively.
This person is not in any teams
This person is not in any offices
Houlihan Lokey
13 followers
Houlihan Lokey (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory. The firm serves corporations, institutions, and governments worldwide with offices in the Americas, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. Houlihan Lokey is the No. 1 investment bank for global M&A transactions under $1 billion, the No. 1 M&A advisor for the past eight consecutive years in the U.S., the No. 1 global restructuring advisor for the past nine consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 25 years, all based on number of transactions and according to data provided by Refinitiv.